News

Weight loss surgery found to cut the overall risk of developing cancers linked to obesity by 20%.
Neuromyelitis optica is the fourth chronic disease that hematopoietic stem cell transplantation has appeared to reverse.
IVIG found to have a good safety profile in pediatric patients, with low risk of severe adverse drug reactions.
Survivors of long-term diffuse large B-cell lymphoma found to have a higher risk of developing a second primary cancer.
Annual Award Celebrates Electronic Health Records, Health Systems and Pharmacy Industry Leaders for Improving Patient Safety and Workflow Efficiency
 
A study looked at the incidence of thrombosis in patients being treated with ibrutinib for hematologic malignancies.
 
Pharmaceutical Mystery
What is causing a positive drug test in a patient that only takes blood pressure medications?
FDA breakthrough designation is based on data for nivolumab plus ipilimumab in a study evaluating the immuno-oncology combination in patients with advanced hepatocellular carcinoma previously treated with sorafenib.
Oligodendrocyte progenitor cells were often ignored by scientists studying multiple sclerosis; however, new research shows that they are critical in its production.
Jonathan Ogurchak, PharmD, CSP, sits down with Specialty Pharmacy Times to discuss how specialty pharmacists can show their value during the NASP Annual Meeting in Washington, DC.
Evidence-based, Outcomes-driven Conflict Management Styles
With expanding pharmacy practice, it is time to explore conflict management, and its necessity in this current climate.
Jesse C. Dresser, Esq explains a recent piece of PBM legislation from North Dakota and its implications for specialty pharmacy at the NASP Annual Meeting in Washington, DC.
+ Load More